<?xml version="1.0" encoding="UTF-8" ?>

    <journal>
    <language>en</language>
    <journal_id_issn>2008-2835</journal_id_issn>
    <journal_id_issn_online>2008-4625</journal_id_issn_online>
    <journal_id_pii></journal_id_pii>
    <journal_id_doi></journal_id_doi>
    <journal_id_isnet></journal_id_isnet>
    <journal_id_iranmedex>276</journal_id_iranmedex>
    <journal_id_magiran>5669</journal_id_magiran>
    <journal_id_sid>11181</journal_id_sid>
    <pubdate>
	    <type>gregorian</type>
	    <year>>2017</year>
	    <month>>April-June</month>
	    <day></day>
    </pubdate>
    <volume>9</volume>
    <number>2</number>
    <publish_type>online</publish_type>
    <publish_edition>1</publish_edition>
    <article_type>fulltext</article_type>
    <articleset>

<article>
	<language>en</language>
	<article_id_issn></article_id_issn>
	<article_id_issn_online></article_id_issn_online>
	<article_id_pubmed>28496946</article_id_pubmed>
	<article_id_pii></article_id_pii>
	<article_id_doi></article_id_doi>
	<article_id_iranmedex></article_id_iranmedex>
	<article_id_magiran></article_id_magiran>
	<article_id_sid></article_id_sid>
	<title_fa></title_fa>
	<title>Alpha Alumina Nanoparticle Conjugation to Cysteine Peptidase A and B: An Efficient Method for Autophagy Induction</title>
	<subject_fa></subject_fa>
	<subject></subject>
	<content_type_fa></content_type_fa>
	<content_type></content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;p&gt;Background: Autophagy as a cellular pathway facilitates several immune responses against infection. It also eliminates invading pathogens through transferring content between the cytosol and the lysosomal vesicles and contributes to the cross-presentation of exogenous antigens to T lymphocytes via MHC class I pathway. Autophagy induction is one of the main targets for new drugs and future vaccine formulations. Nanoparticles are one of the candidates for autophagy induction. Cysteine Peptidase A (CPA) and Cysteine Peptidase B (CPB) are two members of papain family (Clan CA, family C1) enzyme that have been considered as a virulence factor of Leishmania (L.) major, making them suitable vaccine candidates. In this research, Leishmania major cysteine peptidase A and B (CPA and CPB) conjugation to alpha alumina nanoparticle was the main focus and their entrance efficacy to macrophages was assessed.&lt;br /&gt;
Methods: For this purpose, CPA and CPB genes were cloned in expression vectors. Related proteins were extracted from transformed &lt;em&gt;E. coli&lt;/em&gt; and purified using Ni affinity column. Alpha alumina nanoparticles were conjugated to CPA/CPB proteins using Aldehyde/Hydrazine Reaction. Autophagy induction in macrophages was assessed using acridine orange staining.&lt;br /&gt;
Results: CPA/CPB protein loading to nanoparticles was confirmed by Fourier Transform Infrared Spectroscopy. &amp;alpha;-alumina conjugated CPA/CPB antigen uptake by macrophages at different concentrations was confirmed using fluorescence microscope and flowcytometry. Highly efficient CPA/CPB protein loading to &amp;alpha;-alumina nanoparticles and rapid internalization to macrophages introduced these nanocarriers as a delivery tool. Acridine orange staining demonstrated higher autophagy induction in CPA/CPB protein conjugated with &amp;alpha;-alumina nanoparticles.&lt;br /&gt;
Conclusion: &amp;alpha;-alumina nanoparticles may be a promising adjuvant in the development of therapeutic leishmania vaccines through antigen delivery to intracellular compartments, induction of autophagy and cross presentation to CD&lt;sub&gt;8&lt;/sub&gt; lymphocytes.&lt;/p&gt;
</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Autophagy, Cysteine peptidase, Macrophage</keyword>
	<start_page>71</start_page>
	<end_page>81</end_page>
	<web_url>https://www.ajmb.org/En/Article.aspx?id=270</web_url>
    <pdf_url>https://www.ajmb.org/PDF/En/FullText/270.pdf</pdf_url>
	<author_list><author><first_name>Fatemeh</first_name><middle_name></middle_name><last_name>Beyzay</last_name><suffix></suffix><affiliation>Department of Immunology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>1102</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Ahmad</first_name><middle_name></middle_name><last_name>Zavaran Hosseini</last_name><suffix></suffix><affiliation>Department of Immunology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>387</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Sara</first_name><middle_name></middle_name><last_name>Soudi</last_name><suffix></suffix><affiliation>Department of Immunology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>391</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author></author_list>
</article>

</articleset>
</journal>

